CurrentEndo
Get Weekly

CurrentEndo coverage · page 3 of 55

Diabetes, Obesity and Metabolism

Briefs 81–120 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Prevalence and Incidence of Hypoglycaemia Among Patients With Type 2 Diabetes in China—A Prospective Cohort Study

    Cohort studyT2D & other

  2. Diabetes Obes Metab

    Safety, Pharmacokinetics and Pharmacodynamics of the GLP ‐1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo‐Controlled Phase 1a/1b Study

    Randomized controlled trialObesity

  3. Diabetes Obes Metab

    SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network

    Cohort studyT1D

  4. Diabetes Obes Metab

    Postmarketing Safety Signals and Medication‐Use Risks of GLP ‐1‐Based Therapies in Diabetes and Obesity: A Multi‐Source Pharmacovigilance and Regulatory Evidence‐Mapping Study

    Research articleObesity

  5. Diabetes Obes Metab

    Intravenous Oxytocin Does Not Affect Glucose‐Regulating Hormones or Markers of Bone Turnover During Graded Glucose Infusion in Healthy Men

    Randomized controlled trial

  6. Diabetes Obes Metab

    Use of Glucose‐Lowering Drugs for Type 2 Diabetes Among Danish Care Home Residents

    Cohort studyT2D & other

  7. Diabetes Obes Metab

    Sodium–Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage‐Dependent Systemic‐Retinal Responsiveness

    Research articleComplications

  8. Diabetes Obes Metab

    Quality Plus Quantity: Evaluation of a Virtual GLP ‐1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP ‐1 Weight Loss

    Mechanistic studyObesity

  9. Diabetes Obes Metab

    Insulin Efsitora Demonstrates Similar Efficacy and Safety Profiles to Insulin Icodec in Insulin‐Experienced Individuals With Type 2 Diabetes Mellitus: Matching‐Adjusted Indirect Comparisons of QWINT ‐3 Versus ONWARDS 2, and QWINT ‐4 Versus ONWARDS 4

    Randomized controlled trialT2D & other

  10. Diabetes Obes Metab

    Dietary Soybean vs. Palm Oils Differ in Effects on Liver Fat in Adults With MAFLD : A 16‐Week, Double‐Masked, Randomized Controlled Trial

    Randomized controlled trialLipids & liver

  11. Diabetes Obes Metab

    Serum Lipidomics Profiling Identify Novel Biomarkers of Distal Symmetrical Polyneuropathy in Type 1 Diabetes

    Diagnostic or prognostic studyComplications

  12. Diabetes Obes Metab

    Person‐Reported and Continuous Glucose Monitoring ( CGM ) Recorded Hypoglycaemia in People With Insulin‐Treated Type 2 Diabetes and Mild to Moderate Chronic Kidney Disease; Post Hoc Analysis From the Hypo‐ METRICS Study

    Secondary analysisT2D & other

  13. Diabetes Obes Metab

    The Association Between NT ‐Pro BNP , Nephropathy and Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus

    Cross-sectional studyComplications

  14. Diabetes Obes Metab

    Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial

    Randomized controlled trialT2D & other

  15. Diabetes Obes Metab

    Association of Eicosanoids and Eicosanoid‐Related Metabolites With Obesity and Cardiometabolic Traits

    Cross-sectional studyObesity

  16. Diabetes Obes Metab

    A Novel Metabolic Inflammation Index for Cardiovascular Prognosis: Evidence From Three International Cohorts in Middle‐Aged and Older Adults

    Cohort study

  17. Diabetes Obes Metab

    Development of a Parsimonious Sagittal Abdominal Diameter‐Based Model for Estimating Visceral Fat Area in Central Obesity Assessment

    Cross-sectional studyObesity

  18. Diabetes Obes Metab

    Dysglycaemia and Autonomic Dysfunction: The Diabetes Prevention Program Outcomes Study

    Cross-sectional studyT2D & other

  19. Diabetes Obes Metab

    Evaluation of Diabetes Risk Models Applied to the Prediction of Incident Dysglycaemia in African and European Populations

    Diagnostic or prognostic studyT2D & other

  20. Diabetes Obes Metab

    First‐In‐Human Study of Mirogabalin ( BM2216 ) Sustained‐Release Tablets: Safety, Tolerability, Pharmacokinetics, Food Effect and Dose Proportionality With Comparison to Mirogabalin Besylate in Healthy Participants

    Research article

  21. Diabetes Obes Metab

    Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts

    Meta-analysisT2D & other

  22. Diabetes Obes Metab

    Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

    Cohort studyT2D & other

  23. Diabetes Obes Metab

    Pathway‐Specific Polygenic Risk Score and Risk of Hyperglycaemic Progression in Patients With Type 2 Diabetes

    Cohort studyT2D & other

  24. Diabetes Obes Metab

    Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST ‐ T1D Extension Study

    Secondary analysisT1D

  25. Diabetes Obes Metab

    Association of GLP1 ‐Receptor Agonists With Diabetic Retinopathy

    Cohort studyComplications

  26. Diabetes Obes Metab

    Exploratory Analysis of Type 2 Diabetes Mellitus Metabolic Phenotypes and Their Association With Vitamin D Status in Primary Care Patients

    Cross-sectional studyT2D & other

  27. Diabetes Obes Metab

    Increasing Trends in Hospitalisation With Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis Among Children and Youth in the United States and England, 2002–2020

    Cohort studyT1D

  28. Diabetes Obes Metab

    Real‐World Glycemic Outcomes of Open‐Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups

    Cohort studyT1D

  29. Diabetes Obes Metab

    Bidirectional Association Between Diabetes and Osteoarthritis: A Population‐Based Cohort Study

    Cohort studyT2D & other

  30. Diabetes Obes Metab

    Impact of Metformin Plus Lifestyle Intervention Compared With Lifestyle Intervention Alone on Prediabetes Remission in Participants With Impaired Glucose Regulation: The China DPP Study

    Secondary analysisT2D & other

  31. Diabetes Obes Metab

    Improving Short‐ and Long‐Term Type 2 Diabetes Risk Prediction for Middle‐Aged British Adults

    Diagnostic or prognostic studyT2D & other

  32. Diabetes Obes Metab

    Multi‐Dimensional Barriers for Work Productivity and Possible Solutions to Overcome Presenteeism in Young‐Onset Diabetes: A Mixed‐Methods Study

    Research articleT1D

  33. Diabetes Obes Metab

    Associations of Circadian‐Disruptive Behaviours With Plasma Glycemic Parameters and Continuous Glucose Monitoring Measures Among Pregnant Women

    Cohort studyDiabetes in pregnancy

  34. Diabetes Obes Metab

    Cardiorenal Mortality and Safety Outcomes of GLP ‐1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m 2 : A Target Trial Emulation

    Research articleT2D & other

  35. Diabetes Obes Metab

    Insulin Resistance–Adiposity Burden and Incident Cardiovascular Disease Across Glycaemic Transitions in Prediabetes: Risk Stratification After Reversion to Normoglycaemia

    Cohort studyT2D & other

  36. Diabetes Obes Metab

    Integrated Assessment of Abdominal Adiposity and Muscle Strength for Atherosclerotic Cardiovascular Disease Risk in UK Biobank: A Comprehensive Analysis From Population Cohort to Multi‐Omics Molecular Exploration

    Cohort studyObesity

  37. Diabetes Obes Metab

    Maternal Gestational Diabetes and Trajectories of Offspring Fat–Lean Balance in the Millennium Cohort Study

    Cohort studyDiabetes in pregnancy

  38. Diabetes Obes Metab

    Cardiac Autonomic Markers Partly Account for Adiposity‐Related Liver Enzyme Variation in Non‐Diabetic Adults With Overweight or Obesity

    Cross-sectional studyObesity

  39. Diabetes Obes Metab

    Effects of Sarpogrelate Versus Aspirin on Whole Blood Viscosity in Patients With Type 2 Diabetes and Peripheral Artery Disease

    Randomized controlled trialComplications

  40. Diabetes Obes Metab

    Intramuscular Fat Assessed by AI‐Assisted Muscle Ultrasound: Association With Cardiometabolic Risk Factors and Diabetic Nephropathy in Diabetes Mellitus

    Cross-sectional studyComplications

All 2,200 Briefs in ExploreShowing Briefs 81–120 of 2,200, newest first